p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions

scientific article published on 01 April 1998

p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HEP.510270425
P698PubMed publication ID9537449

P2093author name stringRapp UR
Schwarz M
Buchmann A
Troppmair J
Buenemann CL
Kaestner K
Kalkuhl A
Stinchcombe S
P2860cites workBcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1Q24617367
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionQ25938986
Protein kinase C alpha activates RAF-1 by direct phosphorylationQ28260100
Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumorsQ28267177
The ins and outs of Raf kinasesQ28307284
Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signalingQ29617453
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membraneQ29618478
Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitroQ30452723
Striking homology of the ‘Variable’ N-terminal as well as the ‘conserved core’ domains of the mouse and human TATA-factors (TFIID)Q33350959
Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activityQ33676544
14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteinsQ35624026
Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesisQ37389008
Oncogene activation in chemical carcinogenesisQ39559546
Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumorsQ40483537
Transcriptional regulation by extracellular signals: mechanisms and specificityQ40579098
Activators and effectors of ras p21 proteinsQ40757563
MAP kinase kinase kinase, MAP kinase kinase and MAP kinaseQ40757575
Role of receptors in human and rodent hepatocarcinogenesisQ40933381
Ras effectorsQ41099716
Phosphorylation of Raf by ceramide-activated protein kinaseQ41270560
Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouseQ42196397
Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptorQ42796135
Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide seraQ44670247
14-3-3 and its possible role in co-ordinating multiple signalling pathwaysQ47986680
14-3-3 protein homologs required for the DNA damage checkpoint in fission yeastQ48080836
Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours.Q53456254
Absence of mutations in the functional parts of the p120-GAP gene in carcinogen-induced mouse liver tumorsQ53487035
Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H/He miceQ53494621
Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors.Q54213666
Sequence preference of 7,12-dimethylbenz[a]anthracene-syn-diol epoxide-DNA binding in the mouse H-ras gene detected by UvrABC nucleases.Q54584942
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblastsQ59095246
Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cellsQ71118388
Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liverQ72331241
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1081-1088
P577publication date1998-04-01
P1433published inHepatologyQ15724398
P1476titlep21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions
P478volume27

Reverse relations

cites work (P2860)
Q33864770Ah receptor ligands and tumor promotion: survival of neoplastic cells
Q45183645B-raf and Ha-ras mutations in chemically induced mouse liver tumors
Q22011109Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1
Q33916701Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate
Q45408799Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells
Q33964689Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells
Q34348449Searching new targets for anticancer drug design: the families of Ras and Rho GTPases and their effectors
Q42506244Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein.
Q36972045Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only

Search more.